Agile Therapeutics reported 18.47M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adma Biologics ADMA:US $ 222.77M 17.03M
Agile Therapeutics AGRX:US 18.47M 4.12M
Bayer BAYN:GR 39.55B 1.3B
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Pain Therapeutics PTIE:US $ 204.2M 18M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Therapeuticsmd TXMD:US 98.6M 14.18M